MedPath

Development, Implementation and Initiation of Normative Database Quantitative Ultra High Field MRI Paramaters

Not Applicable
Conditions
Healthy
Interventions
Procedure: acquisition of normative database with ultra high field MRI
Device: MRI
Registration Number
NCT02402751
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Brief Summary

The Centre for Magnetic Resonance in Biology and Medicine (CRMBM, UMR-CNRS 7339 AMU) obtained funding for a whole body NMR imaging at 7. It is the only MRI at 7T installed in a hospital in France (only two 7T MRI in France) and therefore a unique opportunity to develop new diagnostic approaches.

The purpose of this study is to develop, implement and validate new MRI quantitative parameters derived from ultra high field MRI in order to characterize non-invasively with an unprecedented resolution and sensitivity, anatomy as well as certain physiological, hemodynamic and metabolic function of brain, spinal cord, musculoskeletal system, and heart in healthy subjects

Detailed Description

The key is that the goal of our projects is not only producing images of better quality than using a 3T scanner but also making images differently, by highlighting new contrasts and features of theses organs in order to improve the diagnosis and prognosis of neurological, psychiatric, cardiovascular and rheumatologic diseases.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • People not presenting contraindications to the MRI (pacemaker, agitation, metallic brightness, claustrophobia etc.)
  • People having no intra-physical object potentially conductive.
  • People having no affection after detailed interrogation
Exclusion Criteria
  • People staying in a sanitary or social establishment
  • People in emergency situation
  • People not wishing to be informed about anomalies in the MRI
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Acquisition of normative databaseMRIDevelopment, implementation and initiation of normative database (image and data) quantitative ultra high field MRI paramaters
Acquisition of normative databaseacquisition of normative database with ultra high field MRIDevelopment, implementation and initiation of normative database (image and data) quantitative ultra high field MRI paramaters
Primary Outcome Measures
NameTimeMethod
qualitative validation concerning structure visible with high field MRI4 years

the validation criteria are qualitative (contrast and visibility of anatomical structures usually visible 7T but not visible at 3T will be used to assess the sensitivity of images for each modality) and quantitative (signal to noise ratio (SNR), spatial and temporal resolution).

Secondary Outcome Measures
NameTimeMethod
acquisition of normative data and verification of the quality criteria obtained during the first phase4 years

During the second phase, we will acquire normative data and verify the quality criteria of the first phase. Each quantitative variable will be extracted. After the acquisition of the first 30 volunteers for each parameter, the variance will be analyzed to assess the population distribution. Depending on the results, and issues raised by clinical research studies, other populations will be acquired

Trial Locations

Locations (1)

Assistance Publique - Hopitaux de Marseille

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath